
CV NEWS FEED // National Health Services (NHS) England has announced that children will no longer be able to take puberty blockers at so-called “gender identity clinics.”
According to an Independent UK report, children will now only be able to obtain puberty blockers “as a part of clinical research trials.”
“The decision comes after a public consultation on the issue and an NHS England-commissioned independent review in 2020 of gender identity services for children under 18,” the report stated.
The review found that there was a mass “rise in referrals to the Gender Identity Development Service (Gids) run by the Tavistock and Portman NHS Foundation Trust,” as of April 2022, which saw over 5,000 referrals to Gids.
A decade earlier, there were just 250.
Following the closure of Tavistock, Gids will shut down at the end of March, and will be replaced by two clinics which will be run by “clinical experts in neurodiversity, paediatrics, and mental health.”
Approximately 250 patients will be transferred to the new clinics, while some 5,000 remain on a waitlist.
